ResMed CapEx increased by 17.9% to $33.65M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 61.8%, from $20.80M to $33.65M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -3.3% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.91M | $27.34M | $30.41M | $48.45M | $28.64M | $29.06M | $27.35M | $28.82M | $34.45M | $30.04M | $23.35M | $21.19M | $24.88M | $17.84M | $20.64M | $20.80M | $30.59M | $42.97M | $28.54M | $33.65M |
| QoQ Change | — | -2.0% | +11.2% | +59.3% | -40.9% | +1.4% | -5.9% | +5.4% | +19.5% | -12.8% | -22.2% | -9.3% | +17.4% | -28.3% | +15.7% | +0.7% | +47.1% | +40.5% | -33.6% | +17.9% |
| YoY Change | — | — | — | — | +2.6% | +6.3% | -10.1% | -40.5% | +20.3% | +3.4% | -14.6% | -26.5% | -27.8% | -40.6% | -11.6% | -1.9% | +22.9% | +140.8% | +38.2% | +61.8% |